Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 2/1997

01-03-1997

MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells

Authors: Helena Pulyaeva, Jorge Bueno, Myriam Polette, Philippe Birembaut, Hiroshi Sato, Motoharu Seiki, Erik W. Thompson

Published in: Clinical & Experimental Metastasis | Issue 2/1997

Login to get access
Metadata
Title
MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells
Authors
Helena Pulyaeva
Jorge Bueno
Myriam Polette
Philippe Birembaut
Hiroshi Sato
Motoharu Seiki
Erik W. Thompson
Publication date
01-03-1997
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 2/1997
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1018444609098

Other articles of this Issue 2/1997

Clinical & Experimental Metastasis 2/1997 Go to the issue

OriginalPaper

Human breast cancer cell metastasis to long bone and soft organs of nude mice: a quantitative assay

OriginalPaper

Inhibition of tumor invasiveness by 1-alpha-25-dihydroxy-vitamin D coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization

OriginalPaper

A novel spontaneous metastasis model of human osteosarcoma developed using orthotopic transplantation of intact tumor tissue into tibia of nude mice

OriginalPaper

Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor

OriginalPaper

Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues

OriginalPaper

Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits